Free Trial

Illumina (ILMN) Competitors

Illumina logo
$136.67 -0.70 (-0.51%)
As of 01/17/2025 04:00 PM Eastern

ILMN vs. A, MTD, WAT, TECH, BIO, CRL, BRKR, PACB, HBIO, and TMO

Should you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry.

Illumina vs.

Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, community ranking, valuation, earnings and institutional ownership.

Illumina received 243 more outperform votes than Agilent Technologies when rated by MarketBeat users. However, 71.11% of users gave Agilent Technologies an outperform vote while only 65.66% of users gave Illumina an outperform vote.

CompanyUnderperformOutperform
Agilent TechnologiesOutperform Votes
864
71.11%
Underperform Votes
351
28.89%
IlluminaOutperform Votes
1107
65.66%
Underperform Votes
579
34.34%

Agilent Technologies has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500. Comparatively, Illumina has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500.

Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Agilent Technologies$6.51B6.47$1.29B$4.4233.39
Illumina$4.50B4.81-$1.16B-$9.96-13.72

Agilent Technologies currently has a consensus target price of $143.62, indicating a potential downside of 2.68%. Illumina has a consensus target price of $165.63, indicating a potential upside of 21.19%. Given Illumina's stronger consensus rating and higher probable upside, analysts plainly believe Illumina is more favorable than Agilent Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Agilent Technologies
1 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.43
Illumina
0 Sell rating(s)
8 Hold rating(s)
10 Buy rating(s)
2 Strong Buy rating(s)
2.70

89.4% of Illumina shares are held by institutional investors. 0.2% of Illumina shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Agilent Technologies has a net margin of 19.80% compared to Illumina's net margin of -36.10%. Agilent Technologies' return on equity of 25.43% beat Illumina's return on equity.

Company Net Margins Return on Equity Return on Assets
Agilent Technologies19.80% 25.43% 13.79%
Illumina -36.10%7.29%3.40%

In the previous week, Illumina had 20 more articles in the media than Agilent Technologies. MarketBeat recorded 33 mentions for Illumina and 13 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.13 beat Illumina's score of 0.45 indicating that Agilent Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Agilent Technologies
10 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Illumina
10 Very Positive mention(s)
3 Positive mention(s)
15 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Agilent Technologies beats Illumina on 10 of the 19 factors compared between the two stocks.

Get Illumina News Delivered to You Automatically

Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ILMN vs. The Competition

MetricIlluminaAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$21.68B$5.92B$5.21B$9.14B
Dividend YieldN/A0.44%5.13%4.02%
P/E Ratio-13.7226.6189.1017.36
Price / Sales4.814.111,241.0577.17
Price / Cash38.1544.7543.7535.97
Price / Book3.782.395.314.79
Net Income-$1.16B$2.94M$122.54M$225.00M
7 Day Performance-5.24%-1.43%0.60%2.62%
1 Month Performance0.48%1.62%2.55%3.81%
1 Year Performance0.58%-20.91%25.29%20.10%

Illumina Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ILMN
Illumina
4.6387 of 5 stars
$136.67
-0.5%
$165.63
+21.2%
+0.6%$21.68B$4.50B-13.729,300
A
Agilent Technologies
4.1635 of 5 stars
$142.59
+3.7%
$143.62
+0.7%
+12.5%$40.72B$6.51B32.2618,100Short Interest ↓
Positive News
MTD
Mettler-Toledo International
4.1592 of 5 stars
$1,264.64
+4.4%
$1,351.25
+6.8%
+8.0%$26.69B$3.76B34.1018,000Positive News
WAT
Waters
4.3951 of 5 stars
$399.98
+5.2%
$384.71
-3.8%
+29.3%$23.75B$2.91B38.177,900
TECH
Bio-Techne
4.0488 of 5 stars
$75.18
+2.6%
$82.00
+9.1%
+7.8%$11.95B$1.17B79.983,100
BIO
Bio-Rad Laboratories
4.0851 of 5 stars
$350.21
+2.5%
$394.20
+12.6%
+11.9%$9.80B$2.58B-12.818,030Short Interest ↑
CRL
Charles River Laboratories International
4.8235 of 5 stars
$190.24
+2.2%
$214.00
+12.5%
-22.8%$9.73B$4.06B23.8121,800Analyst Forecast
Short Interest ↑
Analyst Revision
BRKR
Bruker
4.9757 of 5 stars
$63.05
+3.7%
$74.45
+18.1%
-20.9%$9.56B$3.24B30.318,520Analyst Forecast
PACB
Pacific Biosciences of California
2.1325 of 5 stars
$1.96
-6.7%
$2.95
+50.7%
-75.1%$536.77M$173.15M-1.34730Gap Up
HBIO
Harvard Bioscience
1.1674 of 5 stars
$1.83
-3.7%
N/A-55.1%$79.82M$97.73M-5.55490News Coverage
Positive News
High Trading Volume
TMO
Thermo Fisher Scientific
4.9785 of 5 stars
$556.93
+2.7%
$650.52
+16.8%
+1.4%$213.03B$42.37B34.92122,000News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:ILMN) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners